| 000 | 00762nam a2200217Ia 4500 | ||
|---|---|---|---|
| 005 | 20260808125508.0 | ||
| 008 | 260808s9999||||xx |||||||||||||| ||und|| | ||
| 020 | _a0-913595-38-1 | ||
| 035 | _a6326 | ||
| 041 | _aENG | ||
| 082 | _a615.11 | ||
| 100 | _aUnited States Pharmacopeal Convention Incorporation | ||
| 245 | 0 |
_aUSP xxii NF xvii supplement no - 1 to 8 _bthe national formulary xvii, 1990 with 1 - 8 supplements |
|
| 250 | _a22nd | ||
| 260 |
_aRockville _bUnited States Pharmacopeial Convention Incorporation _c1990 |
||
| 300 | _aliv + 2067 | ||
| 500 | _a3360 / 93 - 94 / 09.07.1993 | ||
| 505 | _aUSP, United States Pharmacopoeia, drug standards, pharmaceutical reference | ||
| 650 |
_aReferences (USP) _bPharmacology -- Therapeutics |
||
| 942 | _cBK | ||
| 999 |
_c6324 _d6324 |
||